Abstract
Patient with lung adenocarcinoma of stage IV, following the six chemotherapy cycles with paclitaxell-carboplatin-Avastin partial remission has confirmed monotherapy with Avastin was confirmed for 22 cycles so far. As an angiogenesis inhibitor Avastin reads to an extensive of overall survival beyond 12 months.